GLOBAL CANCER TECHNOLOGY ANNOUNCES RESEARCH COLLABORATION WITH UNIVERSITY OF NEW MEXICO ON GCT-007 AND GCT-008 IN GLIOBLASTOMA
Global Cancer Technology (GCT), a preclinical-stage biopharmaceutical company developing novel oncology therapeutics, today announced a research collaboration with The University of New Mexico (UNM).